Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents

NCT06957704 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder
Suicidal Ideas

Interventions

DRUG: ketamine
DRUG: Midazolam

Sponsor

Federal University of São Paulo